This inventor holds 2 USPTO granted patents. Top assignee: University of Illinois. Active years: 2008-2010.
Company Filing History:
Years Active: 2008-2010
Title: Farhad Ravandi: Innovator in Cancer Chemotherapy
Introduction
Farhad Ravandi is a notable inventor based in Houston, TX (US). He has made significant contributions to the field of cancer chemotherapy through his innovative work on prodrugs. With a total of 2 patents, Ravandi's inventions focus on enhancing the efficacy of cancer treatments.
Latest Patents
Ravandi's latest patents include methods for enhancing the efficiency of prodrugs by utilizing specifically engineered enzymes. These enzymes exhibit enhanced activity towards nucleoside analogs used in cancer chemotherapy. The invention also details the delivery of these enzymes to specific target cells within a patient. Additionally, it provides modified deoxycytidine kinase (dCK) mutants with enhanced activity. Furthermore, the invention includes antibody-conjugated enzymes that can be specifically delivered to leukemic blast cells, both in vivo and ex vivo.
Career Highlights
Farhad Ravandi is affiliated with the University of Illinois, where he continues to advance research in the field of cancer treatment. His work has garnered attention for its potential to improve therapeutic outcomes for patients undergoing chemotherapy.
Collaborations
Ravandi has collaborated with notable colleagues, including Arnon Lavie and Manfred Konrad, to further his research and innovations in cancer therapy.
Conclusion
Farhad Ravandi's contributions to the field of cancer chemotherapy through his innovative patents demonstrate his commitment to improving patient care. His work continues to pave the way for advancements in cancer treatment methodologies.